Cargando…
Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues
Up to 20% of patients with chronic kidney disease have atrial fibrillation, and 40%-50% of atrial fibrillation patients suffer from chronic kidney disease. The 2 diseases share several risk factors and frequently coincide with each other. Both entities are associated with a prothrombotic state, whic...
Autores principales: | Matusik, Paweł T., Heleniak, Zbigniew, Undas, Anetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797703/ https://www.ncbi.nlm.nih.gov/pubmed/36444964 http://dx.doi.org/10.5152/AnatolJCardiol.2022.2426 |
Ejemplares similares
-
Chronic Kidney Disease and Its Impact on a Prothrombotic State in Patients with Atrial Fibrillation
por: Matusik, Paweł T., et al.
Publicado: (2020) -
Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation
por: Matusik, Paweł T., et al.
Publicado: (2019) -
Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
por: Undas, Anetta
Publicado: (2023) -
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020) -
Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
por: Stoica, Mihai Ciprian, et al.
Publicado: (2021)